Whole genome sequencing as an investigational device for return of hereditary disease risk and pharmacogenomic results as part of the All of Us Research Program

E Venner, D Muzny, JD Smith, K Walker, CL Neben, CM Lockwood, PE Empey, GA Metcalf, The All of Us Research Program Regulatory Working Group, S Mian, A Musick, H Rehm, S Harrison, S Gabriel, R Gibbs, D Nickerson, AY Zhou, K Doheny, B Ozenberger, SE Topper, NJ Lennon
doi: https://doi.org/10.1101/2021.04.18.21255364

Data Availability

Clinical sample data from this study are not publicly available.

Back to top
Posted April 25, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Whole genome sequencing as an investigational device for return of hereditary disease risk and pharmacogenomic results as part of the All of Us Research Program
E Venner, D Muzny, JD Smith, K Walker, CL Neben, CM Lockwood, PE Empey, GA Metcalf, The All of Us Research Program Regulatory Working Group, S Mian, A Musick, H Rehm, S Harrison, S Gabriel, R Gibbs, D Nickerson, AY Zhou, K Doheny, B Ozenberger, SE Topper, NJ Lennon
medRxiv 2021.04.18.21255364; doi: https://doi.org/10.1101/2021.04.18.21255364
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area